E09.353

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula

Header / non-billable

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from E09.35Drug/chem diabetes w proliferative diabetic retinopathy
7th character

One of the following 7th characters is to be assigned to codes in subcategory E09.35 to designate laterality of the disease:

Valid 7th characters and their meanings
CharacterMeaning
1right eye
2left eye
3bilateral
9unspecified eye
Inherited from E09Drug or chemical induced diabetes mellitus
Excludes 1

diabetes mellitus due to underlying condition (E08.-) gestational diabetes (O24.4-) neonatal diabetes mellitus (P70.2) postpancreatectomy diabetes mellitus (E13.-) postprocedural diabetes mellitus (E13.-) secondary diabetes mellitus NEC (E13.-) type 1 diabetes mellitus (E10.-) type 2 diabetes mellitus (E11.-)

Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85) insulin (Z79.4) oral antidiabetic drugs (Z79.84) oral hypoglycemic drugs (Z79.84)

Code first

poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E09.353

FY 2026 ›